Rosenzweig, M <br/><br/>
Light-chain amyloidosis: SCT, novel agents and beyond.  [electronic resource] 

 -  Bone marrow transplantation  Aug 2013 
 - 1022-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2012.199  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloidosis--immunology<br/>Animals<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Dexamethasone--therapeutic use<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Immunoglobulin Light Chains--immunology<br/>Immunologic Factors--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Immunotherapy<br/>Lenalidomide<br/>Melphalan--therapeutic use<br/>Pyrazines--therapeutic use<br/>Survival Analysis<br/>Thalidomide--analogs & derivatives